233 related articles for article (PubMed ID: 24221193)
21. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
Kamiński K; Putowski L; Oleszczuk J
Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
[TBL] [Abstract][Full Text] [Related]
22. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
23. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
24. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
25. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
[TBL] [Abstract][Full Text] [Related]
26. Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression.
Han B; Shen Y; Zhang P; Jayabal P; Che R; Zhang J; Yu H; Fei P
Oncotarget; 2017 Apr; 8(14):22490-22500. PubMed ID: 28157704
[TBL] [Abstract][Full Text] [Related]
27. p21WAF1/CIP1 protein expression in primary ovarian cancer.
Ferrandina G; Stoler A; Fagotti A; Fanfani F; Sacco R; De Pasqua A; Mancuso S; Scambia G
Int J Oncol; 2000 Dec; 17(6):1231-5. PubMed ID: 11078810
[TBL] [Abstract][Full Text] [Related]
28. Two different, mutually exclusively distributed,
Sukhbaatar N; Bachmayr-Heyda A; Auer K; Aust S; Deycmar S; Horvat R; Pils D
Cold Spring Harb Mol Case Stud; 2017 Jul; 3(4):. PubMed ID: 28679689
[TBL] [Abstract][Full Text] [Related]
29. Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.
Brodsky AS; Fischer A; Miller DH; Vang S; MacLaughlan S; Wu HT; Yu J; Steinhoff M; Collins C; Smith PJ; Raphael BJ; Brard L
PLoS One; 2014; 9(4):e94476. PubMed ID: 24732363
[TBL] [Abstract][Full Text] [Related]
30. ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma.
Salzman J; Marinelli RJ; Wang PL; Green AE; Nielsen JS; Nelson BH; Drescher CW; Brown PO
PLoS Biol; 2011 Sep; 9(9):e1001156. PubMed ID: 21949640
[TBL] [Abstract][Full Text] [Related]
31. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
32. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
[TBL] [Abstract][Full Text] [Related]
33. High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.
Paulson V; Chandler G; Rakheja D; Galindo RL; Wilson K; Amatruda JF; Cameron S
Genes Chromosomes Cancer; 2011 Jun; 50(6):397-408. PubMed ID: 21412928
[TBL] [Abstract][Full Text] [Related]
34. The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.
Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
[No Abstract] [Full Text] [Related]
35. Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
Goranova T; Ennis D; Piskorz AM; Macintyre G; Lewsley LA; Stobo J; Wilson C; Kay D; Glasspool RM; Lockley M; Brockbank E; Montes A; Walther A; Sundar S; Edmondson R; Hall GD; Clamp A; Gourley C; Hall M; Fotopoulou C; Gabra H; Freeman S; Moore L; Jimenez-Linan M; Paul J; Brenton JD; McNeish IA
Br J Cancer; 2017 May; 116(10):1294-1301. PubMed ID: 28359078
[TBL] [Abstract][Full Text] [Related]
36. Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.
Birch AH; Arcand SL; Oros KK; Rahimi K; Watters AK; Provencher D; Greenwood CM; Mes-Masson AM; Tonin PN
PLoS One; 2011; 6(12):e28250. PubMed ID: 22163003
[TBL] [Abstract][Full Text] [Related]
37. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer.
Abou-Zeid AA; Azzam AZ; Kamel NA
Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901
[TBL] [Abstract][Full Text] [Related]
38. Distant metastases in ovarian cancer: association with p53 mutations.
Sood AK; Sorosky JI; Dolan M; Anderson B; Buller RE
Clin Cancer Res; 1999 Sep; 5(9):2485-90. PubMed ID: 10499623
[TBL] [Abstract][Full Text] [Related]
39. Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer.
Laudański P; Kowalczuk O; Klasa-Mazurkiewicz D; Milczek T; Rysak-Luberowicz D; Garbowicz M; Baranowski W; Charkiewicz R; Szamatowicz J; Chyczewski L
Folia Histochem Cytobiol; 2011; 49(2):317-24. PubMed ID: 21744334
[TBL] [Abstract][Full Text] [Related]
40. New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach.
Garziera M; Roncato R; Montico M; De Mattia E; Gagno S; Poletto E; Scalone S; Canzonieri V; Giorda G; Sorio R; Cecchin E; Toffoli G
Cells; 2019 Jun; 8(6):. PubMed ID: 31197119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
